Recurrent scrotal hemangiomas during treatment with sunitinib

MeSH terms

• Antineoplastic Agents / adverse effects*
• Bone Density Conservation Agents / therapeutic use
• Bone Neoplasms / drug therapy
• Bone Neoplasms / secondary
• Carcinoma, Renal Cell / drug therapy
• Carcinoma, Renal Cell / secondary
• Diphosphonates / therapeutic use
• Genital Neoplasms, Male / chemically induced*
• Genital Neoplasms, Male / pathology
• Hemangioma / chemically induced*
• Hemangioma / pathology
• Humans
• Imidazoles / therapeutic use
• Indoles / adverse effects*
• Kidney Neoplasms / drug therapy
• Kidney Neoplasms / pathology
• Male
• Middle Aged
• Pyrroles / adverse effects*
• Recurrence
• Scrotum / pathology*
• Skin Neoplasms / chemically induced*
• Skin Neoplasms / pathology
• Sunitinib
• Zoledronic Acid